Literature DB >> 20694490

Boronated phosphonium salts containing arylboronic acid, closo-carborane, or nido-carborane: synthesis, X-ray diffraction, in vitro cytotoxicity, and cellular uptake.

Daniel E Morrison1, Fatiah Issa, Mohan Bhadbhade, Ludwig Groebler, Paul K Witting, Michael Kassiou, Peter J Rutledge, Louis M Rendina.   

Abstract

The preparation of boronated triaryl and tetraaryl phosphonium salts of the type [PPh(3)CH(2)R]Br [R is 4-boronophenyl (1), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-yl)phenyl (2), 3-boronophenyl (3), 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-yl)phenyl (4), 2-boronophenyl (5), 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-yl)phenyl (6), and closo-1,2-carboran-1-yl (7)] is described. These compounds were prepared by the reaction of triphenylphosphine with benzylic bromides or 1-bromomethyl-closo-1,2-carborane in acetonitrile solution at 85 °C. The zwitterionic nido-7,8-carborane derivative PPh(3)CH(2)C(2)B(9)H(11) (8) was prepared by treatment of 7 with cesium fluoride in refluxing ethanol. All compounds were fully characterized by multinuclear ((1)H, (11)B, (13)C, and (31)P) 1D- and 2D-NMR spectroscopy, electrospray ionization mass spectrometry, and elemental analysis, and single-crystal X-ray structures were determined for compounds 1, 3, 7, and 8. The cytotoxicities and boron uptake of selected derivatives were investigated in vitro using human glioblastoma (T98G) and canine kidney tubule (MDCK II) cells. The zwitterionic species 8 was found to be the least cytotoxic agent while also delivering the greatest amount of boron to the T98G cells, peaking at 9.15 ± 2.65 μg B/mg protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694490     DOI: 10.1007/s00775-010-0690-6

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  34 in total

1.  The first carborane triflates: synthesis and reactivity of 1-trifluoromethanesulfonylmethyl- and 1,2-bis(trifluoromethanesulfonylmethyl)-o-carborane.

Authors:  V N Kalinin; E G Rys; A A Tyutyunov; Z A Starikova; A A Korlyukov; V A Ol'shevskaya; D D Sung; A B Ponomaryov; P V Petrovskii; E Hey-Hawkins
Journal:  Dalton Trans       Date:  2005-01-28       Impact factor: 4.390

Review 2.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

3.  Tetraphenylphosphonium as a novel molecular probe for imaging tumors.

Authors:  Jung-Jun Min; Sandip Biswal; Christophe Deroose; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

4.  Antineoplastic activity, synergism, and antagonism of triarylalkylphosphonium salts and their combinations.

Authors:  J Patel; D Rideout; M R McCarthy; T Calogeropoulou; K S Wadwa; A R Oseroff
Journal:  Anticancer Res       Date:  1994 Jan-Feb       Impact factor: 2.480

5.  Basis for the selective cytotoxicity of rhodamine 123.

Authors:  J S Modica-Napolitano; J R Aprille
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

6.  Enhanced in vitro uptake and retention of 3H-tetraphenylphosphonium by nervous system tumor cells.

Authors:  J D Steichen; M J Weiss; D R Elmaleh; R L Martuza
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

7.  Facile S(N)2' coupling reactions of wittig reagents with dimethyl bromomethylfumarate: synthesis of enes, dienes, and related natural products.

Authors:  Ramesh M Patel; Narshinha P Argade
Journal:  J Org Chem       Date:  2007-06-01       Impact factor: 4.354

8.  Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077.

Authors:  J S Modica-Napolitano; K Koya; E Weisberg; B T Brunelli; Y Li; L B Chen
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

9.  Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.

Authors:  Kunio Yokoyama; Shin-Ichi Miyatake; Yoshinaga Kajimoto; Shinji Kawabata; Atsushi Doi; Toshiko Yoshida; Tomoyuki Asano; Mitsunori Kirihata; Koji Ono; Toshihiko Kuroiwa
Journal:  J Neurooncol       Date:  2006-03-24       Impact factor: 4.130

Review 10.  Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.

Authors:  Ellen L Crossley; Erin J Ziolkowski; Jeffrey A Coderre; Louis M Rendina
Journal:  Mini Rev Med Chem       Date:  2007-03       Impact factor: 3.862

View more
  3 in total

1.  Nitroxyl (HNO) reacts with molecular oxygen and forms peroxynitrite at physiological pH. Biological Implications.

Authors:  Renata Smulik; Dawid Dębski; Jacek Zielonka; Bartosz Michałowski; Jan Adamus; Andrzej Marcinek; Balaraman Kalyanaraman; Adam Sikora
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

2.  Reaction between peroxynitrite and triphenylphosphonium-substituted arylboronic acid isomers: identification of diagnostic marker products and biological implications.

Authors:  Adam Sikora; Jacek Zielonka; Jan Adamus; Dawid Debski; Agnieszka Dybala-Defratyka; Bartosz Michalowski; Joy Joseph; Richard C Hartley; Michael P Murphy; Balaraman Kalyanaraman
Journal:  Chem Res Toxicol       Date:  2013-05-09       Impact factor: 3.739

3.  Identification of Peroxynitrite by Profiling Oxidation and Nitration Products from Mitochondria-Targeted Arylboronic Acid.

Authors:  Jacek Zielonka; Adam Sikora; Radoslaw Podsiadly; Micael Hardy; B Kalyanaraman
Journal:  Methods Mol Biol       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.